As of 2025-12-19, the Relative Valuation of Reata Pharmaceuticals Inc (RETA) is (50.48) USD. This relative valuation is based on P/E multiples. With the latest stock price at 172.36 USD, the upside of Reata Pharmaceuticals Inc based on Relative Valuation is -129.3%.
The range of the Relative Valuation is (49.05) - (52.38) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.3x - 20.1x | 19.0x |
| Forward P/E multiples | 18.8x - 20.6x | 19.7x |
| Fair Price | (49.05) - (52.38) | (50.48) |
| Upside | -128.5% - -130.4% | -129.3% |
| Date | P/E |